Colony stimulating factor‑1 receptor promotes proliferation, migration and invasion in the human nasopharyngeal carcinoma 6‑10B cell line via the phosphoinositide 3‑kinase/Akt pathway

Chen,Jiayu; Hao,Yanrong; Chen,Jiaxin; Huang,Li; Ao,Wen; Yang,Jiao; Li,Lei; Heng,Junping; Chen,Zhaohon; Liang,Wuqing; Hao,Xin; Gao,Weiwei

doi:10.3892/ol.2018.8750

Colony stimulating factor‑1 receptor promotes proliferation, migration and invasion in the human nasopharyngeal carcinoma 6‑10B cell line via the phosphoinositide 3‑kinase/Akt pathway

Authors:
- Jiayu Chen
- Yanrong Hao
- Jiaxin Chen
- Li Huang
- Wen Ao
- Jiao Yang
- Lei Li
- Junping Heng
- Zhaohon Chen
- Wuqing Liang
- Xin Hao
- Weiwei Gao
View Affiliations

Affiliations: Cancer Center, Renmin Hospital of Wuhan University, Wuhan, Hubei 430000, P.R. China, Cancer Center, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Autonomous Region 530000, P.R. China
Published online on: May 21, 2018 https://doi.org/10.3892/ol.2018.8750
Pages: 1205-1211

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the effects of colony‑stimulating factor‑1 receptor (CSF‑1R) on proliferation, migration and invasion in the human nasopharyngeal carcinoma (NPC) 6‑10B cell line, and to investigate the possible underlying mechanisms. Using a lentiviral transfection method, a virus carrying the CSF‑1R gene was transfected into 6‑10B cells. The expression of CSF‑1R was then detected by reverse transcription‑quantitative polymerase chain reaction and western blot analysis, and was revealed to be markedly enhanced in 6‑10B cells. Subsequently, an MTT assay was performed to assess cell proliferative ability, and flow cytometric analysis was utilized to measure the apoptotic rate of the cells. Wound healing and Transwell assays were also performed to observe cell migration and invasion capabilities. Additionally, western blot analysis was used to detect the protein expression of the proliferation and apoptosis signaling factors cyclin D1, B‑cell lymphoma 2, Bcl‑2‑associated X protein, and phosphorylated and total extracellular protein kinase B (Akt/PKB) in 6‑10B cells. The results showed that CSF‑1R overexpression promoted the proliferation, migration and invasion of the 6‑10B cells. The corresponding mechanism may be associated with activation of the phosphoinositide 3‑kinase/Akt pathway, which promotes cell survival and proliferation. These results indicated a potential molecular target for the treatment of NPC.

View Figures

View References

1	Razak AR, Siu LL, Liu FF, Ito E, O'Sullivan B and Chan K: Nasopharyngeal carcinoma: The next challenges. Eur J Cancer. 46:1967–1978. 2010. View Article : Google Scholar : PubMed/NCBI
2	Chua DT, Sham JS, Wei WI, Ho WK and Au GK: The predictive value of the 1997 American Joint Committee on cancer stage classification in determining failure patterns in nasopharyngeal carcinoma. Cancer. 11:2845–2855. 2001. View Article : Google Scholar
3	Guo Y, Zhu XD, Qu S, Li L, Su F, Li Y, Huang ST and Li DR: Identification of genes involved in radioresistance of nasopharyngeal carcinoma by integrating gene ontology and protein-protein interaction networks. Int J Oncol. 40:85–92. 2012.PubMed/NCBI
4	Yang S, Chen J, Guo Y, Lin H, Zhang Z, Feng G, Hao Y, Cheng J, Liang P, Chen K, et al: Identification of prognostic biomarkers for response to radiotherapy by DNA microarray in nasopharyngeal carcinoma patients. Int J Oncol. 40:1590–1600. 2012.PubMed/NCBI
5	Huang L, Xu X, Hao Y, Chen J, Li L, Cheng J, Chen Z, Liang W, Yang J and Ao W: Overexpression of CSF-1R in nasopharyngeal carcinoma. Rom J Morphol Embryol. 56:1279–1283. 2015.PubMed/NCBI
6	Yu W, Chen J, Xiong Y, Pixley FJ, Dai XM, Yeung YG and Stanley ER: CSF-1 receptor structure/function in MacCsflr-/-macrophages: Regulation of proliferation, defferetiation, and morphology. J Leukoc Biol. 84:852–863. 2008. View Article : Google Scholar : PubMed/NCBI
7	Beck AH, Espinosa I, Edris B, Li R, Montgomery K, Zhu S, Varma S, Marinelli RJ, van de Rijn M and West RB: The macrophage colony stimulating factor-1 response signature in breast carcinoma. Clin Cancer Res. 15:778–787. 2009. View Article : Google Scholar : PubMed/NCBI
8	Pixley FJ: Macrophage migration and its regulation by CSF-1. Int J Biochem Cell B. 2012:5019622012.
9	Swierczak A, Cook AD, Lenzo JC, Restall CM, Doherty JP, Anderson RL and Hamilton JA: The promotion of breast cancer metastasis caused by inhibition of CSF-1R/CSF-1 signaling is blocked by targeting the G-CSF receptor. Cancer Immunol Res. 2:765–776. 2014. View Article : Google Scholar : PubMed/NCBI
10	Gruessner C, Gruessner A, Glaser K, Abushahin N, Laughren C, Zheng W and Chambers SK: Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma. Am J Cancer Res. 4:61–72. 2014.PubMed/NCBI
11	Kuropkat C, Dünne AA, Plehn S, Ossendorf M, Herz U, Renz H and Werner JA: Macrophage colony-stimulating factor as a tumor marker for squamous cell carcinoma of the head and neck. Tumour Biol. 24:236–240. 2003. View Article : Google Scholar : PubMed/NCBI
12	Gazdar AF and Minna JD: Deregulated EGFR signaling during lung cancer progression: Mutations, amplicons, and autocrine loops. Cancer Prev Res (Phila). 1:156–160. 2008. View Article : Google Scholar : PubMed/NCBI
13	Kirma N, Luthra R, Jones J, Liu YG, Nair HB, Mandava U and Tekmal RR: Overexpression of the colony stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation. Cancer Res. 64:4162–4170. 2004. View Article : Google Scholar : PubMed/NCBI
14	Torti D and Trusolino L: Oncogene addiction as a foundational rationale for targeted anticancer therapy: Promises and perils. EMBO Mol Med. 3:623–636. 2011. View Article : Google Scholar : PubMed/NCBI
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
16	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
17	Kogan M, Haine V, Ke Y, Wigdahl B, Fischer-Smith T and Rappaport J: Macrophage colony stimulating factor regulation by nuclear factor kappa B: A relevant pathway in human immunodeficiency virus type 1 infected macrophages. DNA Cell Biol. 31:280–289. 2012. View Article : Google Scholar : PubMed/NCBI
18	Liu W, Xu GZ, Jiang CH and Tian J: Macrophage colony-stimulating factor and its receptor signaling augment glycated albumin-induced retinal microglial inflammation in vitro. BMC Cell Biol. 12:52011. View Article : Google Scholar : PubMed/NCBI
19	Achkova D and Maher J: Role of the colony-stimulating factor (CSF)/CSF-1 receptor axis in cancer. Biochem Soc Trans. 44:333–341. 2016. View Article : Google Scholar : PubMed/NCBI
20	Foster P, Yamaguchi K, Hsu PP, Qian F, Du X, Wu J, Won KA, Yu P, Jaeger CT, Zhang W, et al: The selective PI3K inhibitor XL147 (SAR245408) inhibits tumor growth and survival and potentiates the activity of chemotherapeutic agents in preclinical tumor models. Mol Cancer Ther. 14:931–940. 2015. View Article : Google Scholar : PubMed/NCBI
21	Li XR, Liu M, Zhang YJ, Wang JD, Zheng YQ, Li J, Ma B and Song X: Evaluation of ER, PgR, HER-2, Ki-67, cyclin D1, and nm23-H1 as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer. Med Oncol. 28(Suppl 1): S31–S38. 2011. View Article : Google Scholar : PubMed/NCBI
22	He Y, Liu Z, Qiao C, Xu M, Yu J and Li G: Expression and significance of Wnt signaling components and their target genes in breast carcinoma. Mol Med Rep. 9:137–143. 2013. View Article : Google Scholar : PubMed/NCBI
23	Kanazawa T, Misawa K, Misawa Y, Uehara T, Fukushima H, Kusaka G, Maruta M and Carey TE: G-protein-coupled receptors: Next generation therapeutic targets in head and neck cancer? Toxins (Basel). 7:2959–2984. 2015. View Article : Google Scholar : PubMed/NCBI
24	Czapiewski P, Wełnicka-Jaśkiewicz M, Seroczyńska B, Skokowski J, Sejda A, Szade J, Wiewiora C, Biernat W and Żaczek A: CD99 correlates with low cyclin D1, high topoisomerase 2 status and triple negative molecular phenotype but is prognostically irrelevant in breast carcinoma. Pol J Pathol. 66:269–275. 2015. View Article : Google Scholar : PubMed/NCBI
25	Zhang Q, Chen X, Zhang X, Zhan J and Chen J: Knockdown of TMEM14A expression by RNAi inhibits the proliferation and invasion of human ovarian cancer cells. Biosci Rep. 36:e002982016. View Article : Google Scholar : PubMed/NCBI
26	Chen Y, Jiang T, Shi L and He K: hcrcn81 promotes cell proliferation through Wnt signaling pathway in colorectal cancer. Med Oncol. 33:32016. View Article : Google Scholar : PubMed/NCBI
27	Zhao Z, Wang L, Song W, Cui H, Chen G, Qiao F, Hu J, Zhou R and Fan H: Reduced miR-29a-3p expression is linked to the cell proliferation and cell migration in gastric cancer. World J Surg Oncol. 13:1012015. View Article : Google Scholar : PubMed/NCBI
28	Lee MS, Ha JH, Yoon HS, Lee CK and Chi SW: Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins. Biochem Biophys Res Commun. 445:120–125. 2014. View Article : Google Scholar : PubMed/NCBI
29	Edison N, Curtz Y, Paland N, Mamriev D, Chorubczyk N, Haviv-Reingewertz T, Kfir N, Morgenstern D, Kupervaser M, Kagan J, et al: Degradation of Bcl-2 by XIAP and ARTS promotes apoptosis. Cell Rep. 21:442–454. 2017. View Article : Google Scholar : PubMed/NCBI
30	Zhou L, Gao R, Wang Y, Zhou M and Ding Z: Loss of BAX by miR-365 promotes cutaneous squamous cell carcinoma progression by suppressing apoptosis. Int J Mol Sci. 18(pii): E11572017. View Article : Google Scholar : PubMed/NCBI
31	Song S, Jacobson KN, McDermott KM, Reddy SP, Cress AE, Tang H, Dudek SM, Black SM, Garcia JG, Makino A and Yuan JX: ATP promotes cell survival via regulation of cytosolic [Ca2+] and Bcl-2/Bax ratio in lung cancer cells. Am J Physiol Cell Physiol. 310:C99–C114. 2016. View Article : Google Scholar : PubMed/NCBI
32	Singh SS, Yap WN, Arfuso F, Kar S, Wang C, Cai W, Dharmarajan AM, Sethi G and Kumar AP: Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine? World J Gastroenterol. 21:12261–12273. 2015. View Article : Google Scholar : PubMed/NCBI
33	Mahajan K and Mahajam NP: PI3K-Independent AKT activation in cancers: A Treasure trove for novel therapeutics. J Cell Physiol. 227:3178–3184. 2012. View Article : Google Scholar : PubMed/NCBI
34	Tan AC, Vyse S and Huang PH: Exploiting receptor tyrosine kinase co-activation for cancer therapy. Drug Discov Today. 22:72–84. 2017. View Article : Google Scholar : PubMed/NCBI